drugset / Trial / NCT07153731
The Clinical Research of Traditional Chinese Medicine Compound Formulas
Phase 4
Not yet recruiting
100 enrolled
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
RandomizedParallel-groupOpen-labelTreatment
Summary
To observe the efficacy and safety of Shenkangling, a traditional Chinese medicine decoction, for renal ischemia-reperfusion injury, and to provide evidence-based medical evidence and ideas for clinical therapeutic use.
Timeline
- Start
- 2025-10-01
- Primary completion
- 2025-10-01
- Completion
- 2027-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Shenkangling | Traditional medicine (herbal / TCM) | 150 ml | Oral |
Indications
No indication recorded.